---
ID: "d2838a17-4afd-48ec-8505-6308a3de98de"
Parent: "c20e860d-13f8-4b95-8551-aa8b264fdf56"
Template: "455a3e98-a627-4b40-8035-e683a0331ac7"
Path: /sitecore/templates/Project/Perskindol/Datasources/News/News Detail/Content/Title
SharedFields:
- ID: "ab162cc0-dc80-4abf-8871-998ee5d7ba32"
  Hint: Type
  Value: "Single-Line Text"
- ID: "ba3f86a2-4a1c-4d78-b63d-91c2779c1b5e"
  Hint: __Sortorder
  Value: 100
Languages:
- Language: en
  Versions:
  - Version: 1
    Fields:
    - ID: "25bed78c-4957-4165-998a-ca1b52f67497"
      Hint: __Created
      Value: 20231106T050108Z
    - ID: "52807595-0f8f-4b20-8d2a-cb71d28c6103"
      Hint: __Owner
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "5dd74568-4d4b-44c1-b513-0af5f4cda34f"
      Hint: __Created by
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "8cdc337e-a112-42fb-bbb4-4143751e123f"
      Hint: __Revision
      Value: "cf792305-0112-45cb-a060-e3f68ecccb33"
    - ID: "badd9cf9-53e0-4d0c-bcc0-2d784c282f6a"
      Hint: __Updated by
      Value: |
        sitecore\ngunguyen@zuelligpharma.com
    - ID: "d9cf14b1-fa16-4ba6-9288-e8a174d4d522"
      Hint: __Updated
      Value: 20231115T041206Z
- Language: "ko-KR"
  Versions:
  - Version: 1
    Fields:
    - ID: "25bed78c-4957-4165-998a-ca1b52f67497"
      Hint: __Created
      Value: 20231108T031617Z
    - ID: "5dd74568-4d4b-44c1-b513-0af5f4cda34f"
      Hint: __Created by
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "8cdc337e-a112-42fb-bbb4-4143751e123f"
      Hint: __Revision
      Value: "fdb1bf32-c87a-4dad-8164-e7f1462cffcc"
    - ID: "badd9cf9-53e0-4d0c-bcc0-2d784c282f6a"
      Hint: __Updated by
      Value: |
        sitecore\dpham@zuelligpharma.com
    - ID: "d9cf14b1-fa16-4ba6-9288-e8a174d4d522"
      Hint: __Updated
      Value: 20231108T031617Z
